Freehand Demonstrates AI Solutions at LogiPharma USA 2026

BOSTON, Oct. 06, 2026 /CourierPR/ -- Freehand, the AI workforce for procurement and accounts payable teams, made a significant presence at the LogiPharma USA 2026 conference, held in Boston from October 5 to 7, 2026. The panel brought together industry leaders from pharmaceutical and life sciences sectors, including Vickran Srivasta of Sun Pharma, Victoria Wilmore of Johnson & Johnson, and Dupre Jones of Accord Healthcare, moderated by Kevin Brophy of SAP.

Jayakrishnan highlighted the volatile nature of pharmaceutical supply chains, noting that the industry has faced unprecedented challenges since the onset of the pandemic. He emphasized the critical role of artificial intelligence (AI) in navigating these complexities and building resilient supply chains.

The company’s AI Teams are designed to handle complex pharma logistics and accounts payable operations, from auditing invoices and enforcing contracts to autonomously investigating and resolving disputes with suppliers and carriers. Freehand’s AI Teams also code transactions, execute payments, and reconcile results, all while allowing enterprises to retain control. According to Jayakrishnan, the result is a new labor model for procure-to-pay that lowers structural costs, stops and recovers spend leakage, accelerates execution, and turns every transaction into intelligence that improves sourcing, procurement, and financial decisions.

Freehand’s solutions are already in use by some of the world’s largest healthcare and pharmaceutical enterprises, including Johnson & Johnson, Pfizer, and Cardinal Health. The company’s AI Teams take on complex AP and spend operations end to end, from sourcing and procurement through audit, disputes, payment, reconciliation, and spend intelligence. Freehand’s proprietary Context Graphs connect enterprise systems, contracts, documents, and communications to understand context, make decisions, and take action.

At the LogiPharma USA 2026 conference, Freehand will demonstrate its AI Teams at booth #426. The company’s booth will showcase how its technology can help organizations build more resilient supply chains and prepare for future disruptions. Freehand’s CEO, Nitin Jayakrishnan, noted that the company’s solutions are crucial for navigating the current and future challenges in the pharmaceutical industry.

In July 2026, Freehand announced that it had raised $75 million in funding from investors including Battery Ventures, NewRoad Capital Partners, PSP Growth, and Nexus Venture Partners. This significant investment underscores the company’s commitment to innovation and its position as a leader in the AI-driven procurement and accounts payable space.

The LogiPharma USA 2026 conference provided a platform for industry leaders to discuss the future of supply chain management and resilience. Freehand’s participation and the keynote panel discussion highlighted the growing importance of AI in ensuring the stability and efficiency of pharmaceutical supply chains. As the industry continues to face unprecedented challenges, companies like Freehand are at the forefront of developing solutions that can help navigate these complexities.